Cosmogene Skincare Private Limited

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience.

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

Unlike traditional PRP therapies that may contain inflammatory cells such as white blood cells (WBCs) and red blood cells (RBCs), Regenexia GFC is a completely acellular solution. Growth factors such as PDGF, VEGF, EGF, and IGF-1 are extracted in their purest, highly concentrated form for maximum efficacy. As the concentrate does not contain WBCs or RBCs, there is a significantly reduced risk of post-procedural pain and inflammation, leading to a more comfortable experience

EXOS-GFC combines the power o f exosomes, mRNA, and growth factors t o play a crucial role in tissue repair and regeneration. Exosomes are nanosized extracellular vesicles that carry bioactive molecules, including mRNA, proteins, and lipids, facilitating cell-to-cell communication and promoting healing. In tissue repair, EXOS-FC delivers growth factors and signaling molecules t o target cells, enhancing angiogenesis, reducing inflammation, and promoting fibroblast proliferation. The mRNA within EXOS-GFC is vital for tissue repair and hair follicle stem cell activation. mRNA delivers genetic instructions to recipient cells, guiding the production of proteins essential for cellular processes. In hair follicle stem cells (HFSCs), mRNA influences gene expression t o activate and maintain their proliferative state, facilitating hair growth and regeneration. Growth factors, such as fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and vascular endothelial growth factor (VEGF), are critical in this process. These growth factors stimulate cellular proliferation, migration, and differentiation. For hair follicle regeneration, growth factors in EXOS-GFC activate HFSCs, encouraging their transition from a quiescent state t o a n active state, thus promoting hair follicle cycling and hair growth. By combining exosomes, mRNA, and growth factors, EXOS-GFC effectively regenerates tissues, repairs damage, and stimulates hair follicle stem cells t o restore hair growth

Additional Information:

• Production Capacity: 10